Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

US Patent 11266681 · Granted Mar 8, 2022

Estimated economic value: $63,247,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, an2025
Crystalline forms of tenofovir alafenamide2025
Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2024
Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treatin2024
Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treatin2024
Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2023
Crystalline forms of tenofovir alafenamide2022
Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo2020
Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treatin2020
Compounds for the treatment of addiction2019
Crystalline forms of tenofovir alafenamide2019
Use of solid carrier particles to improve the processability of a pharmaceutical2018